The Peptide Encyclopedia
Independent, sourced profiles of 30+ peptides. Each entry flags regulatory status honestly β approved medicine, research chemical, or somewhere in between β and links to primary research.
19 peptides
Alexamorelin is a peptide catalogued under Growth Hormone (GHRP). It is described as: Ghrelin receptor. Neutral reference entry; EU status: not approved for human use (research use only).
A long-acting growth-hormone-releasing hormone analog. The DAC variant was studied in early human pharmacokinetic trials.
Examorelin (also known as Hexarelin) is a peptide catalogued under Growth Hormone (GHRP). Neutral reference entry; EU status: not approved for human use (research use only).
A growth-hormone-releasing peptide and ghrelin-receptor agonist used as a diagnostic agent for growth-hormone deficiency in some countries.
A first-generation growth-hormone-releasing hexapeptide and ghrelin-receptor agonist studied for GH stimulation and appetite effects.
Growth hormone (also known as Somatropin) is a peptide catalogued under Growth Hormone (Pituitary hormone). It is described as: GH receptor. Documented context: GH deficiency; Turner syndrome; PWS; adult GHD. Neutral reference entry; EU status: EU-approved prescription medicine.
A potent synthetic growth-hormone-releasing hexapeptide studied for GH release and cardiovascular effects in early research.
IGF-1 DES is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: not approved for human use (research use only).
IGF-1 LR3 is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: not approved for human use (research use only).
Insulin-like growth factor 1 (also known as IGF-1) is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: EU-approved prescription medicine.
A selective growth-hormone secretagogue (ghrelin-receptor agonist) studied for its ability to stimulate growth-hormone release with minimal effect on cortisol or prolactin.
Lonapegsomatropin (also known as Skytrofa) is a peptide catalogued under Growth Hormone (Long-acting PEGylated GH). It is described as: GH receptor. Documented context: Pediatric GHD. Neutral reference entry; EU status: EU-approved prescription medicine.
Mecasermin (also known as Increlex) is a peptide catalogued under Growth Hormone (Recombinant IGF-1). It is described as: IGF-1 receptor. Documented context: Severe primary IGF-1 deficiency. Neutral reference entry; EU status: EU-approved prescription medicine.
MGF (IGF-1 Ec) is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: not approved for human use (research use only).
A modified, stabilized fragment of growth-hormone-releasing hormone (1-29) studied alongside ghrelin-receptor agonists in research settings.
PEG-MGF is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: not approved for human use (research use only).
A growth-hormone-releasing hormone analog historically used in diagnostic testing of pituitary function; once marketed as Geref.
Somatrogon (also known as Ngenla) is a peptide catalogued under Growth Hormone (Long-acting GH analog). It is described as: GH receptor. Documented context: Growth hormone deficiency. Neutral reference entry; EU status: EU-approved prescription medicine.
A stabilized growth-hormone-releasing hormone analog approved (as Egrifta) to reduce excess abdominal fat in HIV-associated lipodystrophy.